Some research institutions have conducted clinical studies and even received approval, such as Mutaflor, approved by Ardeypharman for the relief of ulcerative colitis (UC), and CBM588 for antibiotic-associated diarrhea (AAD), completed in Phase II by Osel, and so on (Biospace, 2022). The ...